Address And Details

605 3rd Ave, 2nd Fl , New York, NY 10158-0180
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Fund seeks growth of capital.To pursue its goal, the Fund normally invests at least 80% of its net assets in equity securities of mid-capitalization companies, which it defines as those with a total market capitalization within the market capitalization range of the Russell Midcap ® Value Index at the time of purchase.The Fund s strategy consists of using a bottom up, fundamental research driven approach to identify stocks of companies that are trading below the Portfolio Manager s estimate of their intrinsic value and that he believes have the potential for appreciation over time. The Portfolio Manager s estimate of a company s intrinsic value represents his view of the company s true, long-term economic worth, the market s view of which may be currently distorted by market inefficiencies. The intrinsic value estimate represents what the Portfolio Manager believes a company could be worth if it is acquired, if its profitability returns to its long-term average level, or if its valuation moves in line with those companies that the Portfolio Manager sees as its publicly traded peers.

Net Asset Value

as of 5:15 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.12%
  • 1 Month
  • -0.78%
  • 3 Months
  • -2.66%
  • 1 Yr Return
  • +51.60%
  • 5 Yr Return
  • +21.62%

Equity Sector Breakdown

NonDurables 16.09%
Finance 13.32%
IndustrialCyclical 12.89%
Utilities 10.89%
RetailTrade 10.86%
Technology 7.21%
Health 6.58%
Services 3.67%
Energy 3.57%
ConsumerDurables 1.49%

Asset Allocation

Asset Type % Of Allocation
Stocks 95.14%
ForeignStocks 8.44%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 6.40 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -16.62 -13.08 -8.30
Beta 1.46 1.41 1.29
R Squared 0.83 0.80 0.80
Std Deviation 29.86 23.64 19.28
Sharpe Ratio 0.25 0.42 n/a

Purchase Information

as of 4:22 PM ET 09/16/2021
Minimum Initial n/a
Minimum Additional $0
Minimum Initial IRA $99

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +53.86%
  • +65.01%
+53.86% +65.01%
3 Year
  • +3.87%
  • +5.85%
+3.87% +5.85%
10 Year
  • +10.50%
  • +9.06%
+10.50% +9.06%
Life Of Fund
  • +8.88%
  • +9.04%
+8.88% +9.04%

Top 10 Holdings

Symbol Company Name % Of Assets
MGM MGM RESORTS INTERNATIONAL 3.68%
AER AERCAP HOLDINGS 3.31%
LGF LIONS GATE ENTERTAINMENT CORP 3.27%
GD GENERAL DYNAMICS CORP 2.99%
TAP MOLSON COORS BREWING CO B 2.85%
APTV APTIV PLC 2.77%
ALXN ALEXION PHARMACEUTICALS INC 2.72%
CSL CARLISLE COS INC 2.71%
REG REGENCY CENTERS CORP 2.68%
JCI JOHNSON CONTROLS INTERNATION 2.52%

Recent Articles from TheStreet

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.